县级提供者密度与肝胆癌发病率和死亡率的关联
Muhammad Muntazir Mehdi Khan1, Muhammad Musaab Munir1, Razeen Thammachack1
1Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA.
World journal of surgery
|August 15, 2024
概括
县内医疗保健提供者密度较高与肝胆癌发病率和死亡率的降低有关. 增加提供者访问可能会改善癌症结果和健康公平.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 提供者密度是医疗质量的关键指标,影响癌症发病率和死亡率.
- 了解提供者密度和肝胆癌之间的联系对于公共卫生战略至关重要.
研究的目的:
- 分析县级提供者密度与肝胆癌发病率和死亡率之间的关联.
- 调查提供者获取如何影响人口层面的癌症结果.
主要方法:
- 利用县级的肝胆癌发病率/死亡率 (2016-2020年) 和提供者密度 (2016-2018年) 的数据.
- 采用多变量逻辑回归来评估提供者密度和癌症率之间的关系.
- 低与高提供者密度县的比较特征,包括人口统计和保险状况.
主要成果:
- 提供者密度较低与所有阶段和晚期肝胆癌发病率和死亡率较高有关.
- 提供者密度较低的县有更高比例的无保险居民和65岁以上的人.
- 提供者密度增加 (中度和高) 与癌症发病率和死亡率的几率降低相关.
结论:
- 较高的县级提供者密度与较低的肝胆癌发病率和死亡率显著相关.
- 加强医疗保健提供者获取的策略可能会改善健康平等和长期癌症存活率.
- 解决供应商短缺问题对于缓解癌症差异至关重要.
相关概念视频
01:12Hazard Ratio
103
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
103
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334